Douglass Winthrop Advisors, LLC Cv Sciences, Inc. Transaction History
Douglass Winthrop Advisors, LLC
- $5.09 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CVSI
# of Institutions
2Shares Held
5.1KCall Options Held
0Put Options Held
0About CV Sciences, Inc.
- Ticker CVSI
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 147,794,000
- Market Cap $5.91M
- Description
- CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...